Oncogene Up-Regulation after Hypomethylating Therapy. Reply
N Engl J Med
.
2022 Aug 4;387(5):476-477.
doi: 10.1056/NEJMc2208134.
Authors
Maria T Voso
1
,
Daniel G Tenen
2
,
Li Chai
3
Affiliations
1
Policlinico Universitario di Roma Tor Vergata, Rome, Italy.
2
Cancer Science Institute of Singapore, Singapore, Singapore daniel.tenen@nus.edu.sg.
3
Brigham and Women's Hospital, Boston, MA.
PMID:
35921466
DOI:
10.1056/NEJMc2208134
No abstract available
Publication types
Letter
Comment
MeSH terms
Azacitidine* / therapeutic use
Demethylation
Humans
Myelodysplastic Syndromes* / therapy
Oncogenes
Up-Regulation
Substances
Azacitidine